Child pages
  • Annotations for Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET (ACNS0332-Tumor-Annotations)

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 15 Next »

Summary

This dataset contains image annotations derived from the NCI Clinical Trial "Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET (ACNS0332)".  This curated dataset provides a comprehensive picture of imaging in pediatric patients with newly diagnosed primitive neuroectodermal tumors throughout their treatment and until any potential relapse. This is the largest known dataset of patients with supratentorial primitive neuroectodermal tumors and pineoblastomas. The key objective of this project was to generate a large and highly curated imaging dataset of pediatric medulloblastoma patients with annotations suitable for cancer researchers and AI developers. 

Annotation Protocol

For each patient, every DICOM Study and DICOM Series was reviewed to identify and annotate clinically relevant time points and sequences. In a typical patient the following time points were annotated:

  1. Pre-surgical study
  2. Post-surgical study [if applicable]
  3. Follow-up study at the completion of radiotherapy.
  4. Follow-up study at the end of chemotherapy.
  5. Follow-up study relapse [if applicable]

At each time point, the following items were annotated:

  1. Enhancing tumor on an axial 3D T1 post contrast sequence
    1. If not available, a 3D post contrast sequence in another plane was used.
    2. If no 3D post contrast sequence was available, the tumor was annotated in all 3 planes utilizing 2D post contrast sequences.
    3. On post-contrast sequences, the entire tumor, including the cystic and non enhancing components was annotated.
    4. Any resection cavity or post-op changes/products was excluded.
  2. Edema on an axial T2 FLAIR sequence
    1. If not available, an axial T2 or other T2 weighted sequence was used.
    2. The segmentation mask contains both the edematous tissue and the tumor.
  3. The portion of the tumor demonstrating restricted diffusion on an ADC sequence
  4. Up to 5 metastatic lesions within the brain and and up to 5 metastatic lesions in the spine as demonstrated on whatever T1 post contrast sequence they are visualized on
    1. When present, the 5 largest lesions were annotated.
  5. A manually placed seed point (kernel) were created for each segmented structure
    1. The seed points for each segmentation are provided in a separate DICOM RTSS file.
    2. Spinal metastases, which are too small to apply a volumetric mask to, only have a seed point annotation.

Important supplementary information and sample code

  1. A spreadsheet containing a variety of useful metadata about the annotations, including calculated tumor volumes, is available in the Data Access section below.
  2. Important information about how to interpret the DICOM annotation data can be found on the Detailed Description tab below.  It includes information about specific tags which document where the tumor was found, whether it was enhancing/non-enhancing, which study time point the annotation relates to, details for lesion tracking across time points, etc.
  3. A Jupyter notebook demonstrating how to use Python to access, visualize, and analyze these data can be found at <INSERT URL>.
  4. Instructions for visualizing these data in 3D Slicer can be found at <INSERT URL>.

Acknowledgements

We would like to acknowledge the individuals and institutions that have provided data for this collection:

  • <May need to put the leidos contract info here>

Data Access

This dataset is limited access. To request access to the image data and annotations please register an account on the NCTN Data Archive.  After logging in, use the "Request Data" link in the left side menu.  Follow the on screen instructions, and enter NCT00392327 when asked which trial you want to request.  In step 2 of the Create Request form, be sure to select “Imaging Data Requested”. Please contact NCINCTNDataArchive@mail.nih.gov for any questions about access requests.

Data TypeDownload all or Query/FilterLicense

Segmentations, Seed Points, and Negative Findings Assessments (DICOM, XX.X GB)


   

(Download requires the NBIA Data Retriever)

Annotation Metadata (CSV)

NCTN/NCORP Data Archive License (Without Collaborative Agreement)


Original ACNS0332 Images with Segmentations  (DICOM, XX.X GB)


  (Download requires the NBIA Data Retriever)

Original ACNS0332 Images with Seed Points (DICOM, XX.X GB)


  (Download requires the NBIA Data Retriever)

Original ACNS0332 Images with Negative Assessments (DICOM, XX.X GB)


  (Download requires the NBIA Data Retriever)

Click the Versions tab for more info about data releases.

Additional Resources for this Dataset

The National Cancer Institute (NCI) has created a centralized, controlled-access database, called the NCTN/NCORP Data Archive, for storing and sharing datasets generated from clinical trials of the National Clinical Trials Network (NCTN) and the NCI Community Oncology Research Program (NCORP). Clinical data from the participants in this trial can be found at:

  • NCTN/NCORP Data Archive (Clinical Data)
  • A Jupyter notebook demonstrating how to access, visualize, and analyze these data in Python using our TCIA REST API can be found at <INSERT URL>.
  • Instructions for visualizing these data in 3D Slicer can be found at <INSERT URL>.

Detailed Description

Image Statistics


Modalities

RTSTRUCT, SEG

Number of Patients

85

Number of Studies

535

Number of Series

2797

Number of Images

2797

Images Size (GB)

Important information contained in the DICOM headers:

  1. Anatomic Region Sequence (0x0008, 0x2218) was inserted containing CNS Segmentation Types as defined in: https://dicom.nema.org/medical/dicom/current/output/chtml/part16/sect_CID_7153.html. In cases where tumor spans multiple regions, multiple location codes were inserted. For example, if the tumor is centered in the parietal lobe, but also involves the frontal and temporal lobes, anatomical codes for all three locations were attached to the structure.
  2. Segmented Property Category Code Sequence (0x0062,0x0003) was inserted into DICOM SEG objects containing one of the following codes:
    • (NCIt, C113842, "Enhancing Lesion")
    • (NCIt, C81175, "Non-Enhancing Lesion")
    • (SNOMED-CT, 14799000, "Neoplasm, Secondary")
    • (SNOMED-CT, 79654002, "Edema")
  3. Tracking ID (0x0062,0x0020) and Tracking UID (0x0062,0x0021) tags were inserted for each segmented structure to enable longitudinal lesion tracking.
  4. A study time point description was inserted into the Clinical Trial Time Point ID (0x0012,0x0050) attribute to help identify each annotation in the context of the clinical trial assessment protocol. The time point description contains one of the following strings: pre-operative, post-operative, post-radiation, post-chemotherapy, or recurrence. Additionally, a Concept Name Code Sequence (0x0040, 0xA043) and Concept Code Sequence (0x0040,0xA168) were added to Acquisition Context Sequence (0x0040, 0x0555).The former defines a Time Point Type concept and latter is populated with one of the following concepts:
    • (SNOMED-CT, 262068006, "Pre-operative")
    • (SNOMED-CT, 262061000, "Post-operative")
    • (SNOMED-CT, 264908009, "Post-radiation")
    • (SNOMED-CT, 262502001, "Post-chemotherapy")
    • (SNOMED-CT, 25173007, "Recurrent tumor (finding)")
  5. For reviewed studies with no radiologic findings, a "negative" DICOM SEG and/or RTSS file are provided. These files contain no segmentation or contour data, but still contain pertinent metadata in Clinical Trial Time Point ID, Acquisition Context Sequence, Anatomic Region Sequence, and Segmented Property Category Code Sequence. The primary motivation for providing these annotations is to capture the information that no radiologic findings (e.g. progression or new metastatic disease) were found during review.


Citations & Data Usage Policy

Users must abide by the TCIA Data Usage Policy and Restrictions. Attribution should include references to the following citations:


Data Citation

Rozenfeld, M., & Jordan, P. (2022). Annotations for Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET (ACNS0332-Tumor-Annotations) (Version 1) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/D8A8-6252

TCIA Citation

Clark K, Vendt B, Smith K, Freymann J, Kirby J, Koppel P, Moore S, Phillips S, Maffitt D, Pringle M, Tarbox L, Prior F. The Cancer Imaging Archive (TCIA): Maintaining and Operating a Public Information Repository, Journal of Digital Imaging, Volume 26, Number 6, December, 2013, pp 1045-1057. DOI: 10.1007/s10278-013-9622-7

Other Publications Using This Data

TCIA maintains a list of publications which leverage TCIA data. If you have a manuscript you'd like to add please contact the TCIA Helpdesk.

Version X (Current): Updated yyyy/mm/dd

Data TypeDownload all or Query/Filter
Images (DICOM, xx.x GB)
Clinical Data (CSV)Link
Other (format)

<< One or two sentences about what you changed since last version.  No note required for version 1. >> 



  • No labels